glatiramer acetate with placebo

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Multiple SclerosisRelapse Remitting Multiple Sclerosis

Phase 2

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

CompletedNCT00203112

Teva Branded Pharmaceutical Products R&D, Inc.Relapse Remitting Multiple Sclerosis

Start: 2004-06-30End: 2006-07-31Updated: 2011-04-12

Phase 4

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

CompletedNCT00240032

Teva Branded Pharmaceutical Products R&D, Inc.Multiple Sclerosis

Start: 2004-10-31End: 2006-07-31Updated: 2011-04-11